Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleMIT Technology Review

The scientist using AI to hunt for antibiotics just about everywhere

View original at technologyreview.com
MIT Technology Review - Ai Research Title: The scientist using AI to hunt for antibiotics just about everywhere Date: 2026-02-16 11:00 Source: https://www.technologyreview.com/2026/02/16/1132516/cesar-de-la-fuente-using-ai-antibiotics-hunt/ <p>When he was just a teenager trying to decide what to do with his life, César…
Opening lines of the source · MIT Technology Review · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • These peptides haven't yet been transformed into usable drugs that help people

    80% confidence
  • It's only been a few years since folks have been using AI meaningfully in drug discovery

    80% confidence
  • The use, overuse, and misuse of antibiotics drives antimicrobial resistance

    80% confidence
  • De la Fuente is marvelously talented, very innovative

    80% confidence
  • De la Fuente has really helped pioneer the space of harnessing AI for real-world problems

    80% confidence
  • Drug discovery in any domain is a statistics game. You need enough shots on goal to happen to get one

    80% confidence
  • This is the world that we live in today, and it's incredible

    80% confidence
  • AI has already saved decades of human research time

    80% confidence
  • Antimicrobial resistance deaths could surge past 8 million by 2050

    80% confidence
  • Many companies that attempted antibiotic development have folded because there's no good return on investment

    80% confidence
  • Researchers have moved from using predictive models to developing generative approaches

    80% confidence
  • Antimicrobial resistance is an almost impossible problem

    80% confidence
  • The world of antibiotic development needs as much creativity and innovation as researchers can muster

    80% confidence
  • The antibiotic discovery pipeline remains perilously thin, impeded by high development costs, lengthy timelines, and low returns on investment

    80% confidence
  • Biology is an information source like a bunch of code

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com